Fmc-Gateway Dialysis Center-East is a medicare approved dialysis facility center in San Diego, California and it has 24 dialysis stations. It is located in San Diego county at 720 Gateway Center Drive, Suite B, San Diego, CA, 92102. You can reach out to the office of Fmc-Gateway Dialysis Center-East at (619) 264-4100. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fmc-Gateway Dialysis Center-East has the following ownership type - Profit. It was first certified by medicare in January, 1989. The medicare id for this facility is 052678 and it accepts patients under medicare ESRD program.
| Name | Fmc-Gateway Dialysis Center-East |
|---|---|
| Location | 720 Gateway Center Drive, Suite B, San Diego, California |
| No. of Dialysis Stations | 24 |
| Medicare ID | 052678 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 720 Gateway Center Drive, Suite B, San Diego, California, 92102 | |
| (619) 264-4100 | |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
| NPI Number | 1386756187 |
| Organization Name | Gateway Dialysis Center-east |
| Doing Business As | San Diego Dialysis Services, Inc. |
| Address | 720 Gateway Center Dr San Diego, California, 92102 |
| Phone Number | (619) 264-4100 |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 66% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 14% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 20% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 63% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 26% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 11% | 14% |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 60% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 17% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 23% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 66% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 23% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 11% | 12% |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 74% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 26% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 73% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 14% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 13% | 12% |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 73 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 8 |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 147 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1456 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fmc-Gateway Dialysis Center-East with elevated calcium levels.
| Patients with hypercalcemia | 156 |
| Hypercalcemia patient months | 1534 |
| Patients with Serumphosphor | 161 |
| Patients with Serumphosphor less than 3.5 mg/dL | 13 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 28 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 23 |
| Patients with Serumphosphor greater than 7 mg/dL | 10 |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 109 |
| Patient months included in arterial venous fistula and catheter summaries | 982 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 55 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 3 |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 109 |
| Hospitalization Rate in facility | 88.9 (Better than Expected) |
| Hospitalization Rate: Upper Confidence Limit | 173.4 |
| Hospitalization Rate: Lower Confidence Limit | 50.4 |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at Fmc-Gateway Dialysis Center-East were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 15 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 24.4 |
| Readmission Rate: Lower Confidence Limit | 8.1 |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fmc-Gateway Dialysis Center-East get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .81 (As Expected) |
| SIR: Upper Confidence Limit | 1.69 |
| SIR: Lower Confidence Limit | .33 |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fmc-Gateway Dialysis Center-East's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 102 |
| Transfusion Rate in facility | 1.4 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 47 |
| Transfusion Rate: Lower Confidence Limit | .1 |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at Fmc-Gateway Dialysis Center-East lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 647 |
| Mortality Rate in facility | 13.9 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 18 |
| Mortality Rate: Lower Confidence Limit | 10.6 |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago
Fmc-Hillcrest Dialysis Location: 3960 Third Avenue, San Diego, California, 92103 Phone: (619) 299-3900 |
Fmc-Balboa Kearny Mesa Dialysis Center Location: 7927 Ostrow Street, Suite A, San Diego, California, 92111 Phone: (858) 571-0232 |
Fmc-Chula Vista Dialysis Center-South Location: 2252 Verus Street, Suite D, San Diego, California, 92154 Phone: (619) 429-9201 |
Fmc-Gateway Dialysis Center-East Location: 720 Gateway Center Drive, Suite B, San Diego, California, 92102 Phone: (619) 264-4100 |
RAI Care Centers Of Southern California, Llc Location: 7007 Mission Gorge Road, 1st Floor, San Diego, California, 92120 Phone: (619) 229-1070 |
News Archive
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the year ended March 31, 2011, as well as financial results for the fourth quarter.
NYU School of Medicine announced the creation of a new Department of Population Health focused on research to improve human health at the population level. Marc Gourevitch, MD, MPH, professor of population health and medicine at NYU School of Medicine was appointed inaugural chair.
A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.
A 12-month study mapping bacterial diversity within a hospital -; with a focus on the flow of microbes between patients, staff and surfaces -; should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.
› Verified 5 days ago